Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-01-29 @ 9:18 PM
Study NCT ID:
NCT02440568
Status:
TERMINATED
Last Update Posted:
2021-07-06
First Post:
2015-05-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients
Sponsor:
Organization: